Our in-house and partner developers identify pharmaceutical products to develop undifferentiated, differentiated and enhanced generics.
Each project is assessed against technical and commercial criteria to determine its suitability to become a full development project.
Our development pipeline has generated in excess of £25m revenue since 2006.
Animalcare sells its products to veterinary wholesalers in bulk. These products are then sold by the wholesalers to their veterinary practice customers.
Similarly, some pharmaceutical products are sold to our European partners to distribute in their home territories.
Our marketing team provides promotional literature for our sales team and support materials to help veterinary professionals explain medical conditions and therapies to their pet owning clients.
Our highly trained sales team call on veterinary practices across the UK to promote our products and services, thereby pulling demand through the veterinary wholesalers.
The regular visits from our sales representatives mean we have first hand experience of what our customers need, and can channel their feedback back to our development team.
Our database staff receives over 100,000 calls a year from owners updating their contact details and animal welfare professionals wanting to reunite lost pets.